Soltani K - Search Results

1

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.

Maitland ML, Levine MR, Lacouture ME, Wroblewski KE, Chung CH, Gordon IO, Szeto L, Ratko G, Soltani K, Kozloff MF, Hoffman PC, Salgia R, Carbone DP, Karrison TG, Vokes EE. Maitland ML, et al. Among authors: soltani k. BMC Cancer. 2014 Jan 4;14:5. doi: 10.1186/1471-2407-14-5. BMC Cancer. 2014. PMID: 24386952 Free PMC article. Clinical Trial.

2

Human papillomavirus-associated dysplastic condyloma of the tongue treated with Mohs micrographic surgery.

Lacouture ME, Kolanko E, Wang LC, Shea CR, Soltani K. Lacouture ME, et al. Among authors: soltani k. Dermatol Surg. 2005 Apr;31(4):477-9. doi: 10.1111/j.1524-4725.2005.31119. Dermatol Surg. 2005. PMID: 15871329

3

The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies.

Kondapalli L, Soltani K, Lacouture ME. Kondapalli L, et al. Among authors: soltani k. J Am Acad Dermatol. 2005 Aug;53(2):291-302. doi: 10.1016/j.jaad.2005.02.011. J Am Acad Dermatol. 2005. PMID: 16021125 Review.

4

Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.

Lacouture ME, Baron JM, Jani AB, Laumann AE, Soltani K. Lacouture ME, et al. Among authors: soltani k. Clin Exp Dermatol. 2005 Jan;30(1):46-8. doi: 10.1111/j.1365-2230.2004.01659.x. Clin Exp Dermatol. 2005. PMID: 15663503

5

Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.

Lacouture ME, Desai A, Soltani K, Petronic-Rosic V, Laumann AE, Ratain MJ, Stadler WM. Lacouture ME, et al. Among authors: soltani k. Clin Exp Dermatol. 2006 Nov;31(6):783-5. doi: 10.1111/j.1365-2230.2006.02223.x. Epub 2006 Jul 4. Clin Exp Dermatol. 2006. PMID: 16824050

6

Ossified soft tissue leiomyoma in a patient with sickle cell anemia.

Xu Y, Lacouture M, Petronic-Rosic V, Soltani K, Shea CR. Xu Y, et al. Among authors: soltani k. J Cutan Pathol. 2005 Nov;32(10):696-9. doi: 10.1111/j.0303-6987.2005.00435.x. J Cutan Pathol. 2005. PMID: 16293183

7

KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.

Liu W, Lacouture ME, Jiang J, Kraus M, Dickstein J, Soltani K, Shea CR. Liu W, et al. Among authors: soltani k. J Cutan Pathol. 2006 Sep;33 Suppl 2:46-51. doi: 10.1111/j.1600-0560.2006.00539.x. J Cutan Pathol. 2006. PMID: 16972955

8

PTEN positively regulates UVB-induced DNA damage repair.

Ming M, Feng L, Shea CR, Soltani K, Zhao B, Han W, Smart RC, Trempus CS, He YY. Ming M, et al. Among authors: soltani k. Cancer Res. 2011 Aug 1;71(15):5287-95. doi: 10.1158/0008-5472.CAN-10-4614. Epub 2011 Jul 19. Cancer Res. 2011. PMID: 21771908 Free PMC article.

9

Keratoacanthomas and skin neoplasms associated with suramin therapy.

Kobayashi K, Pezen DS, Vogelzang NJ, Medenica M, Janisch L, Ratain M, Vokes EE, Soltani K. Kobayashi K, et al. Among authors: soltani k. Arch Dermatol. 1996 Jan;132(1):96-8. doi: 10.1001/archderm.132.1.96. Arch Dermatol. 1996. PMID: 8546498 No abstract available.

10

Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.

Hallahan DE, Griem ML, Griem SF, Medenica M, Soltani K, Lorincz AL, Baron JM. Hallahan DE, et al. Among authors: soltani k. J Clin Oncol. 1988 Jul;6(7):1177-83. doi: 10.1200/JCO.1988.6.7.1177. J Clin Oncol. 1988. PMID: 3392562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page